HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
MCFD2
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit
Chromosome 2 Β· 2p21
NCBI Gene: 90411Ensembl: ENSG00000180398.14HGNC: HGNC:18451UniProt: B4DF17
54PubMed Papers
21Diseases
0Drugs
12Pathogenic Variants
FUNCTIONAL ROLE
Transporter
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingendoplasmic reticulum-Golgi intermediate compartment membraneendoplasmic reticulum to Golgi vesicle-mediated transportER to Golgi transport vesicle membranecombined deficiency of factor V and factor VIIIneurodegenerative diseasefactor V and factor VIII, combined deficiency of, type 1multiple intestinal atresia
✦AI Summary

MCFD2 is a soluble EF-hand-containing protein that forms a 1:1 stoichiometric complex with the transmembrane lectin LMAN1 to function as a cargo receptor for ER-to-Golgi transport 1. This LMAN1-MCFD2 complex mediates calcium-dependent, glycosylation-independent transport of coagulation factors V and VIII from the endoplasmic reticulum to the Golgi 1. Recent evidence indicates MCFD2 primarily binds cargo proteins while LMAN1 serves as a shuttling carrier, with MCFD2 capable of recruiting factor V and VIII to COPII vesicle budding sites 2. Beyond coagulation factors, the complex also transports Ξ±1-antitrypsin in a glycosylation-dependent manner 3. Loss-of-function mutations in MCFD2 cause combined deficiency of coagulation factors V and VIII (F5F8D), a rare autosomal recessive bleeding disorder with plasma factor levels typically 5-27% of normal 4. MCFD2 mutations are the predominant genetic cause in certain populations 4. Mouse models reveal MCFD2-deficient mice have lower factor levels than LMAN1-deficient mice, suggesting distinct cargo-specific functions 5. Therapeutically, RNAi-mediated inhibition of the LMAN1-MCFD2 complex reduces factor VIII levels and prolongs coagulation time, suggesting potential as an anticoagulant strategy 6.

Sources cited
1
MCFD2 primarily binds cargo while LMAN1 acts as a shuttling carrier; MCFD2 sufficient to rescue secretion defects
PMID: 36490287
2
LMAN1-MCFD2 form 1:1 stoichiometric complex; interact with factor VIII via B domain; calcium-dependent, glycosylation-independent interaction
PMID: 15886209
3
MCFD2 mutations are predominant cause of F5F8D in Indian patients; factor levels 5-27% of normal
PMID: 17610559
4
LMAN1-MCFD2 complex transports Ξ±1-antitrypsin in glycosylation-dependent manner
PMID: 35322856
5
MCFD2-deficient mice have lower factor levels than LMAN1-deficient mice; distinct functions for LMAN1 and MCFD2
PMID: 29735583
6
RNAi targeting LMAN1-MCFD2 reduces factor VIII activity and prolongs coagulation time; potential anticoagulant approach
PMID: 39222205
Disease Associationsβ“˜21
combined deficiency of factor V and factor VIIIOpen Targets
0.72Strong
neurodegenerative diseaseOpen Targets
0.53Moderate
factor V and factor VIII, combined deficiency of, type 1Open Targets
0.46Moderate
multiple intestinal atresiaOpen Targets
0.42Moderate
neuroinflammatory disorderOpen Targets
0.33Weak
ThrombocytopeniaOpen Targets
0.29Weak
Abnormal bleedingOpen Targets
0.29Weak
HypoventilationOpen Targets
0.28Weak
gastrointestinal defect and immunodeficiency syndromeOpen Targets
0.27Weak
severe combined immunodeficiencyOpen Targets
0.27Weak
Reduced quantity of Von Willebrand factorOpen Targets
0.26Weak
Reduced von Willebrand factor activityOpen Targets
0.26Weak
genetic disorderOpen Targets
0.19Weak
gastrointestinal defects and immunodeficiency syndrome 1Open Targets
0.15Weak
obesityOpen Targets
0.12Weak
gallbladder diseaseOpen Targets
0.09Suggestive
cervical carcinomaOpen Targets
0.08Suggestive
Abruptio PlacentaeOpen Targets
0.08Suggestive
multiple myelomaOpen Targets
0.08Suggestive
plasma fibronectin deficiencyOpen Targets
0.07Suggestive
Factor V and factor VIII combined deficiency 2UniProt
Pathogenic Variants12
NM_139279.6(MCFD2):c.149+5G>ALikely pathogenic
Factor 5 and Factor VIII, combined deficiency of, 2|Factor V and factor VIII, combined deficiency of, type 1|MCFD2-related disorder
β˜…β˜…β˜†β˜†2023
NM_139279.6(MCFD2):c.47T>C (p.Leu16Pro)Likely pathogenic
Factor 5 and Factor VIII, combined deficiency of, 2
β˜…β˜†β˜†β˜†2024β†’ Residue 16
NM_139279.6(MCFD2):c.379_380dup (p.Asp127fs)Likely pathogenic
Factor V and factor VIII, combined deficiency of, type 1
β˜…β˜†β˜†β˜†2019β†’ Residue 127
NM_139279.6(MCFD2):c.364G>A (p.Asp122Asn)Likely pathogenic
Abnormal bleeding;Thrombocytopenia
β˜†β˜†β˜†β˜†2020β†’ Residue 122
NM_139279.6(MCFD2):c.241G>T (p.Asp81Tyr)Pathogenic
Factor 5 and Factor VIII, combined deficiency of, 2
β˜†β˜†β˜†β˜†2008β†’ Residue 81
NM_139279.6(MCFD2):c.309+1G>APathogenic
Factor 5 and Factor VIII, combined deficiency of, 2
β˜†β˜†β˜†β˜†2003
NM_139279.6(MCFD2):c.103del (p.Gln35fs)Pathogenic
Factor 5 and Factor VIII, combined deficiency of, 2
β˜†β˜†β˜†β˜†2003β†’ Residue 35
NM_139279.6(MCFD2):c.249del (p.Asp83fs)Pathogenic
Factor 5 and Factor VIII, combined deficiency of, 2|not provided
β˜†β˜†β˜†β˜†2003β†’ Residue 83
NM_139279.6(MCFD2):c.265_272del (p.Asp89fs)Pathogenic
Factor 5 and Factor VIII, combined deficiency of, 2
β˜†β˜†β˜†β˜†2003β†’ Residue 89
NM_139279.6(MCFD2):c.387C>G (p.Asp129Glu)Pathogenic
Factor 5 and Factor VIII, combined deficiency of, 2
β˜†β˜†β˜†β˜†2003β†’ Residue 129
NM_139279.6(MCFD2):c.407T>C (p.Ile136Thr)Pathogenic
Factor 5 and Factor VIII, combined deficiency of, 2
β˜†β˜†β˜†β˜†2003β†’ Residue 136
NM_139279.6(MCFD2):c.-6-1668_*2631delLikely pathogenic
Reduced quantity of Von Willebrand factor;Reduced von Willebrand factor activity
β˜†β˜†β˜†β˜†
View on ClinVar β†—
Related Genes
SEC22CShared pathway100%YIF1AShared pathway100%YIPF6Shared pathway100%TEX261Shared pathway100%F5Protein interaction100%F8Protein interaction100%
Tissue Expression6 tissues
Liver
100%
Ovary
78%
Heart
69%
Brain
58%
Lung
56%
Bone Marrow
30%
Gene Interaction Network
Click a node to explore
MCFD2SEC22CYIF1AYIPF6TEX261F5F8
PROTEIN STRUCTURE
Preparing viewer…
PDB4YGB Β· 1.60 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.37LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.83 [0.52–1.37]
RankingsWhere MCFD2 stands among ~20K protein-coding genes
  • #8,332of 20,598
    Most Researched54
  • #2,690of 5,498
    Most Pathogenic Variants12
  • #14,255of 17,882
    Most Constrained (LOEUF)1.37
Genes detectedMCFD2
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Separate roles of LMAN1 and MCFD2 in ER-to-Golgi trafficking of FV and FVIII.
PMID: 36490287
Blood Adv Β· 2023
1.00
2
Mutations in the MCFD2 gene are predominant among patients with hereditary combined FV and FVIII deficiency (F5F8D) in India.
PMID: 17610559
Haemophilia Β· 2007
0.90
3
Mammalian cargo receptors for endoplasmic reticulum-to-Golgi transport: mechanisms and interactions.
PMID: 37334845
Biochem Soc Trans Β· 2023
0.80
4
Mutations in the MCFD2 gene and a novel mutation in the LMAN1 gene in Indian families with combined deficiency of factor V and VIII.
PMID: 16044454
Am J Hematol Β· 2005
0.70
5
LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway.
PMID: 15886209
J Biol Chem Β· 2005
0.60